Biocept

(OTC) BIOCQ

Current Price$0.00

Market Cap$500.00

Since IPO (2014)-100%

5 Year-100%

1 Year+100%

1 Month+100%

Biocept Financials at a Glance

Market Cap

$500.00

Revenue (TTM)

-$8.02M

Net Income (TTM)

-$39.42M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4550.96 (High)

Dividend

$0.00

Beta (Volatility)

4550.96 (High)

Price

$0.00

Volume

145

Open

$0.00

Price

$0.00

Volume

145

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Aug 18, 2026

Dividend

$0.00

Beta (Volatility)

4550.96 (High)

Price

$0.00

Volume

145

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

Aug 18, 2026

BIOCQ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biocept

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Samuel D. Riccitelli

Website

www.biocept.com

Headquarters

San Diego, CA 92121, US

BIOCQ Financials

Key Financial Metrics (TTM)

Gross Margin

-10%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$500.00

Shares Outstanding

2.63M

Volume

145

Avg. Volume

357.031

Financials (TTM)

Gross Profit

-$2.58M

Operating Income

-$31.98M

EBITDA

-$30.24M

Operating Cash Flow

-$13.29M

Capital Expenditure

-$807.00K

Free Cash Flow

-$14.10M

Cash & ST Invst.

$12.90M

Total Debt

$12.11M

Biocept Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$589.00K

N/A

Gross Profit

-$1.96M

N/A

Gross Margin

-3.33%

N/A

Market Cap

$500.00

N/A

Market Cap/Employee

$10.00

N/A

Employees

N/A

Net Income

-$3.63M

N/A

EBITDA

-$2.92M

N/A

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Total Cash

$6.63M

N/A

Total Debt

$11.59M

N/A

Accounts Receivable

$800.00K

N/A

Inventory

$551.00K

N/A

Long Term Debt

$9.69M

N/A

Short Term Debt

$1.91M

N/A

Return on Assets

-1.04%

N/A

Return on Invested Capital

-1.26%

N/A

Free Cash Flow

-$3.18M

N/A

Operating Cash Flow

-$3.09M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PEMTFThoughtful Brands Inc.

PEMTFThoughtful Brands Inc.$0.00+0.00%

NBRVFNabriva Therapeutics plc

NBRVFNabriva Therapeutics plc$0.00+0.00%

OMDDOrmand Industries Inc

OMDDOrmand Industries Inc$0.00+0.00%

CWWBFPlant-Based Investment Corp.

CWWBFPlant-Based Investment Corp.$0.00+0.00%

BSPMBiostar Pharmaceuticals, Inc.

BSPMBiostar Pharmaceuticals, Inc.$0.00+0.00%

HTGMQHTG Molecular Diagnostics, Inc.

HTGMQHTG Molecular Diagnostics, Inc.$0.00+0.00%

MDVLQMedAvail Holdings, Inc.

MDVLQMedAvail Holdings, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$82.41-0.16%

Questions About BIOCQ

What is the current price of Biocept?

Biocept is trading at $0.00 per share.

What is the 52-week range for Biocept?

Over the past 52 weeks, Biocept has traded between $0.00 and $0.10.

How much debt does Biocept have?

As of the most recent reporting period, Biocept reported total debt of $12.11M.

How much cash does Biocept have on hand?

Biocept reported $12.90M in cash and cash equivalents in its most recent financial results.

What is Biocept’s dividend yield?

Biocept does not currently have a dividend yield.

Biocept

Biocept Financials at a Glance

BIOCQ News

Why RH, Biocept, and Lowe's Jumped Today

Why Biocept, Inc. Is Rebounding Big-Time Today

Why Biocept, Inc. Stock Is Plunging Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biocept

BIOCQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biocept Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIOCQ

What is the current price of Biocept?

What is the 52-week range for Biocept?

How much debt does Biocept have?

How much cash does Biocept have on hand?

What is Biocept’s dividend yield?

Premium Investing Services